Showing results (1881-1890 of 1,977) with videos related to
Sort By:
Pageof 198
Frontiers in Oncology|March 30, 2026
Women with suspected diagnosis of ovarian cancer in Ghana: how much do we know about them?Kwabena Amo-Antwi, Yvonne Nartey, Ramatu Agambire, et al.Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.Biorxiv : the Preprint Server for Biology|July 15, 2025
Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer PathwaysCharles Ochieng' Olwal, Ujjwal Rathore, Sara Makanani, et al.Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.BMC Health Services Research|April 1, 2026
Coffee and tea intake and stroke events among West Africans: findings from the SIREN StudyOsahon Jeffery Asowata, Mary Oyeronke Oyewole, Adekunle Fakunle, et al.International Journal of Environmental Research and Public Health|August 7, 2021
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side EffectsAbanoub Riad, Holger Schünemann, Sameh Attia, et al.Trends in Biotechnology|June 13, 2018
Building Capacity for a Global Genome Editing Observatory: Institutional DesignKrishanu Saha, J Benjamin Hurlbut, Sheila Jasanoff, et al.Journal of the American Heart Association|May 31, 2019
Echocardiographic Abnormalities and Determinants of 1-Month Outcome of Stroke Among West Africans in the SIREN StudyAbiodun M Adeoye, Bruce Ovbiagele, Joshua O Akinyemi, et al.Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.Pageof 198